Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma

Journal of Clinical Oncology

Volumn 22, Issue 14, 2004, Pages 2774-2780

  Ajani, Jaffer A ^a   Mansfield, P F ^a   Janjan, N ^a   Morris, J ^a   Pisters, P W ^a   Lynch, P M ^a   Feig, B ^a   Myerson, R ^a   Nivers, R ^a   Cohen, D S ^a   Gunderson, L L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT; FOLIC ACID;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; LAPAROSCOPY; MULTICENTER STUDY; PREOPERATIVE CARE; PRIORITY JOURNAL; SAFETY; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; ADULT; AGED; FEMALE; GASTRECTOMY; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY; STOMACH TUMOR; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLIC ACID; GASTRECTOMY; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4344654904     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.015     Document Type: Article

References (24)

1. Bonenkamp JJ, Hermans J, Sasako M. van de Velde CJH: Extended lymph node dissection for gastric cancer. N Engl J Med 340:908-914, 1999
2. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base report on poor survival of US gastric carcinoma patients treated with gastrectomy. Cancer 88:921-932, 2000
3. Wanebo HJ, Kennedy BJ, Chmiel J, et al: Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg 218:583-592, 1993
4. Adashek K, Sanger J, Longmire WP: Cancer of the stomach: Review of consecutive ten-year intervals. Ann Surg 198:6-10, 1979
5. Macdonald JS, Smalley S, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001
6. Hundahl SA, Menck HR, Mansour EG, Winchester DP: The National Cancer Data Base report on gastric carcinoma. Cancer 80:2333-2341, 1997
7. Siewert JR, Bottcher K, Stein HJ, et al: Relevant prognostic factors in gastric cancer: Ten-year results of the German gastric cancer study. Ann Surg 228:449-461, 1998
8. Kim JP, Lee JH, Kim SJ, et al: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1:125-133, 1998
9. McNeer G, Vanderberg H, Donn F, et al: A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach. Ann Surg 134:1-7, 1951
10. Thomson FB, Robins RE. Local recurrence following subtotal resection for gastric carcinoma. Surg Gynecol Obstet 95:341-344, 1952
11. Wisbeck WM, Becher EM, Russell AH: Adenocarcinoma of the stomach: Autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol 7:13-18, 1986
12. Gunderson LL, Sosin H: Adenocarcinoma of the stomach: Areas of failure in a reoperation series (second or symptomatic looks): Clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1-11, 1982
13. Landry J, Tepper J, Wood W, et al: Analysis of survival and local control following surgery for gastric cancer. Int J Radiat Oncol Biol Phys 19:1357-1362, 1990
14. Xiong HQ, Gunderson LL, Yao J, et al: Chemoradiation for resectable gastric cancer. Lancet Oncol 4:498-505, 2003
15. Ajani JA, Mayer RJ, Ota DM, et al: Preoperative and postoperative chemotherapy for potentially resectable gastric carcinoma. J Natl Cancer Inst 85:1839-1844, 1993
16. Ajani JA, Mansfield PF, Lynch PM, et al: Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol 17:2403-2411, 1999
17. Lowy AM, Feig BW, Janjan N, et al: A pilot study of preoperative chemoradiotherapy for resectable gastric cancer. Ann Surg Oncol 8:519-524, 2001
18. Zhang ZX, Gu XZ, Yin WB, et al: Randomized clinical trial combination on the preoperative irradiation and surgery in the treatment of adenocarcinoma of the gastric cardia (AGO: Report on 370 patients. Int J Radiat Oncol Biol Phys 42:929-934, 1998
19. Leichman L, Silberman H, Leichman CG, et al: Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: A University of Southern California pilot program. J Clin Oncol 10:1933-1942, 1992
20. Allum W, Cunningham D, Weeden S, et al: Perioperative chemotherapy in operable gastric and lower oesophageal cancer: A randomized, controlled trial (the MAGIC trial, ISRCTN 93793971). Proc Am Soc Clin Oncol 22:249, 2003 (abstr 998)
21. Ajani JA: Operate on my stomach cancer? Oh no, not you, or not yet. J Clin Oncol 22:1763-1764, 2004
22. Estes NC, Macdonald JS, Touijer K, et al: Inadequate documentation and resection for gastric cancer in the Untied States: A preliminary report. Am Surg 64:680-685, 1987
23. Hundahl SA, Macdonald JS, Benedetti J, et al: Surgical treatment variation in a porspective, randomiized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment. Ann Surg Oncol 9:278-286, 2002
24. Gibson MK, Forastiere AA: Combined-modality therapy for esphogeal cancer: Are we making progress? Cancer J 9:238-239, 2003